📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Protocol for the Psychosis Immune Mechanism Stratified Medicine (PIMS) trial: a randomised double-blind placebo-controlled trial of single-dose tocilizumab in patients with psychosis. (2023)

First Author: Foley ÉM

Attributed to: Physical and mental health multimorbidity across the lifespan (LIfespaN multimorbidity research Collaborative (LINC)). funded by SPF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2022-067944

PubMed Identifier: 36963796

Publication URI: http://europepmc.org/abstract/MED/36963796

Type: Journal Article/Review

Volume: 13

Parent Publication: BMJ open

Issue: 3

ISSN: 2044-6055